Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

Fulcrum Therapeutics Inc. (FULC) Climbs 48%

August 10, 2021 8:29 AM EDT

Fulcrum Therapeutics Inc. (NASDAQ: FULC) Climbs 48%

Earlier Fulcrum Therapeutics Inc. (FULC) Announces Positive Interim Results from Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease... More